| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |